Ohio bills · 136th Legislature (2025-2026)
Ohio HB 263
Cap cost sharing for prescription insulin drugs, diabetes devices
- Introduced
- In committee
- Passed House
- Passed Senate
- To Governor
- Became law
Sponsors
- Thomas Hall (Republican)
- Munira Abdullahi (Democratic)
Cosponsors (21)
- Erika White (Democratic)
- Daniel P. Troy (Democratic)
- Eric Synenberg (Democratic)
- Bride Rose Sweeney (Democratic)
- Anita Somani (Democratic)
- Veronica R. Sims (Democratic)
- Tristan Rader (Democratic)
- Beryl Piccolantonio (Democratic)
- Ismail Mohamed (Democratic)
- Joseph A. Miller, III (Democratic)
- Lauren McNally (Democratic)
- Crystal Lett (Democratic)
- Dani Isaacsohn (Democratic)
- Derrick Hall (Democratic)
- Michele Grim (Democratic)
- Christine Cockley (Democratic)
- Karen Brownlee (Democratic)
- Darnell T. Brewer (Democratic)
- Juanita O. Brent (Democratic)
- Sean P. Brennan (Democratic)
- Rachel B. Baker (Democratic)
Summary
Official abstract published by the Ohio legislature· long title
To enact section 3902.65 of the Revised Code to cap cost sharing for prescription insulin drugs, diabetes devices, and diabetic ketoacidosis devices.
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- May 14, 2025 · House
Referred to committee - May 13, 2025 · House
Introduced